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INTRODUCTION
The Medicare Access and CHIP
Reauthorization Act (MACRA) changes
reimbursement from a fee-for-service payment
system to fee-for-value. Physicians will be
scored according to the quality of their care in
the MIPS program and will receive a positive or
negative modifier to their Medicare
reimbursement based on that score.

OBJECTIVE:
To analyze a cost-effective model for
Negative Pressure Wound Therapy (NPWT)
devices with attention to how a MIPS score is
affected.

MATERIAL AND METHODS
Three devices from KCI and Smith &
Nephew each were compared for costeffectiveness and MIPS score impact. From
KCI, the V.A.C.Ulta, ActiV.A.C., and SNaP
devices were compared to the S&N RENASYS,
RENASYS GO, and PICO devices respectively.
Impact on the MIPS sections of Quality, Cost,
and Clinical Practice Improvement Activities
(CPIA) were taken into account. Participation in
Alternative Payment Models was not analyzed.

typically indicated for. If a wound requires
inpatient care, the KCI V.A.C.Ulta with
instillation therapy is the better choice because it
reduces infection rates and treats more complex
wounds faster than traditional NPWT as seen
with the RENASYS device. This improves the
Quality score because of lower infection rates
and it improves the Cost score because wounds
heal faster and discharge comes earlier. If the
wound can be cared for on an outpatient basis,
the KCI SNaP mechanical device is the best
option because it is the cheapest, most costeffective choice over the S&N PICO device. The
SNaP and PICO devices are better options than
the ActiV.A.C and RENASYS GO devices
because they are ultra-lightweight, require no
canister for exudate, and can fit in a discreet
pouch or pocket which is highly beneficial for
patient satisfaction and the CPIA section score.
If the wound can be cared for on an outpatient
basis, but is too large or produces too much
exudate for the SNaP and PICO devices, the
KCI ActiV.A.C and S&N RENASYS Go
devices are better options. Between these two
devices the RENASYS GO is more cost
effective and thus improves the Cost score.

RESULTS & CONCLUSION
Due to the variability of wound
treatment, the devices were compared to each
other based on the types of wounds they are
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